Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Naloxone Hydrochloride, a generic naloxone hydrochloride product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)